Sai-Hong Ignatius Ou

Sai-Hong Ignatius Ou

University of California Irvine
在 uci.edu 的电子邮件经过验证
被引用次数：54459
Medical Oncology Targeted therapy Lung cancer Developmental therapeutics
David M Hyman

David M Hyman

Loxo Oncology, Eli Lilly
在 loxooncology.com 的电子邮件经过验证
被引用次数：40907
Oncology Precision Medicine Cancer Genomics Developmental Therapeutics Early Drug Development
Dan Theodorescu MD, PhD

Dan Theodorescu MD, PhD

Cedars Sinai Medical Center
在 cshs.org 的电子邮件经过验证
被引用次数：32067
Cancer Biology and Genetics Developmental Therapeutics Immunotherapy Biomarkers
Stephen Mack

Stephen Mack

Cleveland Clinic
在 ccf.org 的电子邮件经过验证
被引用次数：16865
Brain cancer epigenetics genomics developmental therapeutics
James J Harding, MD

James J Harding, MD

Memorial Sloan Kettering Cancer Center
在 mskcc.org 的电子邮件经过验证
被引用次数：14440
Gastrointestinal Oncology Developmental Therapeutics Immunotherapy Immunology Signaling Pathways
Albiruni Ryan Abdul Razak

Albiruni Ryan Abdul Razak

Princess Margaret Cancer Centre/Mount Sinai Hospital/University of Toronto
在 uhn.ca 的电子邮件经过验证
被引用次数：11121
Sarcoma Developmental Therapeutics
Terzah Horton

Terzah Horton

Associate Professor of Pediatric Oncology, Baylor College of Medicine
在 txch.org 的电子邮件经过验证
被引用次数：6008
protein homeostasis developmental therapeutics
Deborah Doroshow

Deborah Doroshow

Icahn School of Medicine at Mount Sinai
在 mssm.edu 的电子邮件经过验证
被引用次数：5330
Developmental therapeutics lung cancer history of American medicine
Gregory Friberg, MD

Gregory Friberg, MD

Amgen Inc.
在 amgen.com 的电子邮件经过验证
被引用次数：5248
Cancer Developmental Therapeutics Hematology Oncology
Randy F. Sweis

Randy F. Sweis

University of Chicago
在 uchicago.edu 的电子邮件经过验证
被引用次数：3002
Cancer Immunology Genitourinary Oncology Developmental Therapeutics Phase I Trials Clinical Pharmacology
1 - 10